This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
737 4119, 518 6688
katrin.kaarna@ut.ee, katrin.kaarna@kliinikum.ee

Career

Institutions and positions
01.01.2020–...   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Clinical Research Centre (National Centre of Translational and Clinical Research project), Head of Centre (1,00)
01.08.2017–...   
Tartu University Hospital, Clinical Research Coordinator (0,50)
01.08.2017–...   
University of Tartu, Faculty of Medicine, National Centre of Translational and Clinical Research (CTM) project, Project Manager (1,00)
1998–...   
MEDEX Private Clinic, Neurologist (0,10)
2014–2020   
Tahe Outdoors, Board Member (0,10)
1998–2017   
QuintilesIMS (now named IQVIA), Founder and CEO at Quintiles Estonia OÜ; Clinical Research Manager of Baltic States; Strategy Director of Central Europe; Global Lead and Team Member of the ’Risk Based’ monitoring and change management implementation team, Senior Director Clinical Operations (1,00)
1995–1998   
Lundbeck Estonia OÜ, Product Manager (1,00)
 
 
Additional information
Member of Research Ethics Committee of the University of Tartu (since June 13, 2019)
Certified expert of Good Clinical Practice (GCP) for Clinical Trials
Member of L. Puusepp named Neurology and Neurosurgery Society
Member of Estonian Psychiatric Association
Member of Tartu Hansa Rotary Club (in 2014 to 2015 President of the Club)
Member of the Scientific Committee of ALLEA, EASAC, FEAM joint project "International Transfer of Health Data"
Member of Medical devices technical committee of Estonian Centre for Standardisation

Projects in progress

22.02.2021
737 4119, 518 6688
katrin.kaarna@ut.ee, katrin.kaarna@kliinikum.ee

Teenistuskäik

Töökohad ja ametid
01.01.2020–...   
Tartu Ülikool, meditsiiniteaduste valdkond, kliinilise meditsiini instituut, kliiniliste uuringute keskus (projekt Riiklik siirdemeditsiini ja kliiniliste teadusuuringute keskus), keskuse juhataja (1,00)
01.08.2017–...   
SA Tartu Ülikooli Kliinikum, kliiniliste teadusuuringute koordinaator (0,50)
01.08.2017–...   
Tartu Ülikool, meditsiiniteaduste valdkond, projekt Riiklik siirdemeditsiini ja kliiniliste teadusuuringute keskus (RSKTK), projekti tegevjuht (1,00)
1998–...   
MEDEX Päevakirurgia Erakliinik, neuroloog (0,10)
2014–2020   
Tahe Outdoors, nõukogu liige (0,10)
1998–2017   
QuintilesIMS (praegune nimi IQVIA), Quintiles Estonia OÜ asutaja ja tegevjuht; Quintiles Kesk–Euroopa strateegia juht; Globaalse “Risk Based” monitooringute implementeerimise muudatuste meeskonna liige ja juht, Globaalse kliinilise üksuse vanemdirektor (1,00)
1995–1998   
Lundbeck Estonia OÜ, tootejuht (1,00)
 
 
Lisainfo
Tartu Ülikooli inimuuringute eetika komitee liige (alates 13.06.2019)
GCP (Good Clinical Practice in Clinical Trials) ekspert
Ludvig Puusepa nimelise Neuroloogide ja Neurokirurgide Seltsi liige
Eesti Psühhiaatrite Seltsi liige
Tartu Hansa Rotary Klubi liige (2014-2015 klubi president)
ALLEA, EASAC, FEAM ühisprojekti "International Transfer of Health Data" teaduskomitee liige
MTÜ Eesti Standardikeskuse Meditsiiniseadmete tehnilise komitee liige

Jooksvad projektid

Juhendatud väitekirjad

22.02.2021

Search project

  • {{item.Name}}
Institution is projects' financier   Institution is projects' executor  
  • {{searchListItem.Name}}
All   Projects   Master projects   Subprojects  
New Frascati (2015)
Old and new Frascati
All
Ongoing
Finished
Beginning
Fuzzy
Precise
  • Found 10 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
1.2.3.4.MMVCM20443R (952516)Ethically Responsible INnovations in reproductive medicine01.09.202031.08.2023Andres SalumetsUniversity of Tartu, Faculty of Medicine, Institute of Clinical Medicine382 750,00 EUR
2.2.1.VMVMV18394Kliinilise hinnangu koostamine Pharma Systems AB tooteportfellile21.08.201801.11.2018Katrin KaarnaUniversity of Tartu, Faculty of Medicine33 333,34 EUR
1.1.5.3.4.1.2.SMVMV17082TCentre for clinical research01.01.201630.04.2021Külli KingoUniversity of Tartu, Faculty of Medicine, Dean's Office, Faculty of Medicine622 123,95 EUR
1.1.7.LMVBS20513Follow-up study of Coronavirus SARS-CoV-2 antibodies seroepidemiology study in Estonia01.08.202031.03.2021Irja LutsarUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine128 673,00 EUR
1.1.7.1.SMVBS20329CorSARS-CoV-2 seroepidemiology in Estonia (a test-study in two different areas. KoroSero-EST01.05.202031.12.2020Irja LutsarUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine300 000,00 EUR
1.1.5.3.4.1.3.3.SP1GY19493T (MOBEIT004)Support activities in Mobilitas Pluss EIT MOBEIT004 EIT- Health Mobilitas- 201.04.201931.10.2022Taivo RaudUniversity of Tartu, Support Units, Grant Office200 000,00 EUR
HOSPICOVI; RITA2RITA2/126Elaboration of prognostic measures and potential therapies based on severe cases of COVID-19 patients01.02.202131.07.2022Joel StarkopfUniversity of Tartu, Faculty of Medicine, Institute of Clinical Medicine166 666,67 EUR
MUULMVCM21079 (RITA2/126)Elaboration of prognostic measures and potential therapies based on severe cases of COVID-19 patients01.02.202131.07.2022Joel StarkopfUniversity of Tartu, Faculty of Medicine, Institute of Clinical Medicine166 666,67 EUR
2.1.1.LMVCM20373REDCap database creation and management01.07.202031.12.2022Katrin KaarnaUniversity of Tartu, Faculty of Medicine, Institute of Clinical Medicine4 980,83 EUR
MUULMVCMKUKMonitorig of clinical study "Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients"01.09.202001.09.2031Katrin KaarnaUniversity of Tartu, Faculty of Medicine, Institute of Clinical Medicine4 250,00 EUR